Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 573.98KNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
Sector
Industry
History
$ 1.42Close
$ 1.42 - $ 4.45 52-Week Range
Ticker Information
Ticker
APRECompany Name
APREA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQAPREA THERAPEUTICS INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
APRE - CF - Equity Historical data
| Date | Net Cash Flow - Issuance (Purchase) of Equity Shares |
|---|---|
| 6/30/2025 | $ 573.98K |
| 3/31/2025 | $ 168.04K |
| 12/31/2024 | $ 14.82M |
| 9/30/2024 | $ 14.69M |
| 6/30/2024 | $ 14.69M |
| 3/31/2024 | $ 14.71M |
| 12/31/2023 | $ 5.14M |
| 9/30/2023 | $ 5.24M |
| 6/30/2023 | $ 5.82M |
| 3/31/2023 | $ 5.82M |
Key Performance Insights, Last 5 Years
- APREA THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Equity stands at $ 87.11M.
- Over the past 5 years, APREA THERAPEUTICS INC's average CF - Equity has been $ 8.87M.
- The median CF - Equity for APREA THERAPEUTICS INC during this period was $ 2M
- APREA THERAPEUTICS INC reached its highest CF - Equity over the past 5 years at $ 87.11M.
- The lowest CF - Equity recorded by APREA THERAPEUTICS INC in the same timeframe $ 0
APREA THERAPEUTICS INC's CF - Equity vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Equity Benchmarks
Similar metrics to CF - Equity:
- Net Cash Flow - Issuance (Repayment) of Debt Securities - [Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from issuance (repayment) of debt.
- Net Cash Flow - Financing - [Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.
- Net Cash Flow - Dividends & Other Cash Distributions - [Cash Flow Statement] A component of cash flow from financing [NCFF], representing dividends and dividend equivalents paid on common stock and restricted stock units.
- Buyback Yield - [Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.
- Net Cash Flow - Business Acquisitions and Disposals - [Cash Flow Statement] A component of cash flow from investing [NCFI], representing the net amount of cash to acquire (outflow) or dispose (inflow) businesses, join-ventures, affiliates or other investments.
Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares
[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).APRE - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years
$ 0
Minimum
Jun 30, 2021
$ 87.11M
Maximum
Sep 30, 2020
$ 8.87M
Average
$ 2M
Median
CF - Equity Benchmark AnalysisMarket
The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 107.22K with a standard deviation of $ 17.65M.
The following table provides additional summary stats:
CF - Equity in the Market:
| filtered constituents | 2.89K |
|---|---|
| min | $ -60.59M |
| max | $ 60.64M |
| average | $ 107.22K |
| median | $ 0 |
| std | $ 17.65M |